ADAM15 and cancer: Of note, the reduction in ADAM15 expression was also associated with the acquisition of integrin α5β1 and downregulation of integrin α3β1 integrin and E-cadherin by cancer cells, which are hallmarks of the epithelial–mesenchymal transition (EMT) process that characterizes colon cancer progression and poor prognosis.